Alpha DNA Investment Management’s Mimecast Limited MIME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,795
Closed -$1.5M 168
2021
Q4
$1.5M Sell
18,795
-3,108
-14% -$234K 0.94% 77
2021
Q3
$1.39M Sell
21,903
-5,406
-20% -$331K 0.95% 63
2021
Q2
$1.45M Buy
27,309
+15,432
+130% +$725K 0.99% 53
2021
Q1
$477K Sell
11,877
-2,533
-18% -$112K 0.55% 95
2020
Q4
$819K Buy
+14,410
New +$666K 0.87% 36

Other funds holding MIME

Alpha DNA Investment Management's MIME Position: Q1 2022 in Review

Alpha DNA Investment Management sold out of Mimecast Limited (MIME) in Q1 2022, closing a stake of 18,795 shares — an estimated $1.5M sold.

Alpha DNA Investment Management first reported a position in MIME in Q4 2020 and held it in 5 quarters. The position peaked at $1.5M in Q4 2021. 270 funds tracked by Wall St. Rank hold MIME as of Q1 2022.

  • Alpha DNA Investment Management reported no remaining Mimecast Limited position as of Q1 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 18,795 Mimecast Limited shares in Q1 2022, an estimated $1.5M.
  • Alpha DNA Investment Management first reported a position in Mimecast Limited in Q4 2020 and held it in 5 quarters.
  • Alpha DNA Investment Management's Mimecast Limited position peaked at $1.5M in Q4 2021.
  • 270 funds tracked by Wall St. Rank held Mimecast Limited as of Q1 2022.

Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.